Amedisys Completes Home Health Joint Venture with the University of Arkansas for Medical Sciences
By:
Amedisys, Inc. via
GlobeNewswire
December 13, 2022 at 07:30 AM EST
LITTLE ROCK, Ark. and NASHVILLE, Tenn., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, has closed on its joint venture with the University of Arkansas for Medical Sciences (UAMS) to provide home health services in Searcy and Little Rock. This joint venture is part of the partnership between UAMS, Amedisys and Contessa, an Amedisys company, to offer patients a full spectrum of medical care in the comfort and convenience of their own homes through UAMS Health Comprehensive Care at Home. Clinical services will include Recovery Care at Home, Rehabilitation Care at Home, Palliative Care at Home, Primary Care at Home and Home Health. Home health services include skilled nursing care; physical, occupational and speech therapy; medical social work; and home health aides to assist with activities of daily living, such as bathing, dressing and eating. Home health services will operate as UAMS Health Home Health across 12 counties in Central Arkansas. “Amedisys is proud to partner with UAMS to provide a comprehensive program that will improve the outcomes and experiences for our patients in Central Arkansas,” stated Amedisys Chairman and CEO Paul Kusserow. “Along with Contessa, our partnership allows us to offer the first-of-its-kind model to the region and the first Comprehensive Care at Home program to the state. This also marks the first partnership where Amedisys and Contessa are delivering this integrated model of comprehensive care in the home from the outset - a model we look to provide with other innovative health system partners nationwide.” “UAMS is leading the ambitious goal of making Arkansas the healthiest state in the region, and this strategic initiative supercharges that vision,” said Cam Patterson, M.D., MBA, UAMS chancellor and CEO of UAMS Health. “We are thrilled to partner with Contessa and Amedisys to bring this first-of-its-kind model to the region and the first Comprehensive Care at Home program to the state. We look forward to giving our patients an innovative option that delivers on our commitment of community-focused, patient-centered care.” Amedisys’ home health operations now include 353 care centers in 35 states, with an average daily census of approximately 70,000 patients and approximately 11,000 home health employees. In 2022, Modern Healthcare named Amedisys, Inc. to its prestigious Best Places to Work in Healthcare list for the second consecutive year. Amedisys is the second largest provider of home health care and the third largest provider of hospice care in the United States. As of the October 2022 Home Health Compare release, Amedisys’ Quality of Patient Care (QPC) Star score is 4.44. The Company also provides hospice care, personal care, palliative care and high-acuity care. About UAMS About Contessa Based in Nashville, the company currently partners with 12 health systems and 30 health plans serving patients in nine states. Alongside Amedisys’s 21,000+ employees in 37 states, the company has the ability to serve more patients in a full care continuum, from primary care to end-of-life, all in the comfort of home. For more information, visit contessahealth.com or follow us at @contessahealth. About Amedisys Forward-Looking Statements: Words like “believes,” “belief,” “expects,” “strategy,” “plans,” “anticipates,” “intends,” “projects,” “estimates,” “may,” “might,” “will,” “could,” “would,” “should” and similar expressions are intended to identify forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a variety of risks and uncertainties that could cause actual results to differ materially from those described therein. These risks and uncertainties include, but are not limited to the following: the impact of the novel coronavirus pandemic (“COVID-19”), including the measures that have been and may be taken by governmental authorities to mitigate it, on our business, financial condition and results of operations; the impact of current and proposed federal, state and local vaccine mandates; staffing shortages driven by the competitive labor markets; changes in or our failure to comply with existing federal and state laws or regulations or the inability to comply with new government regulations on a timely basis; changes in Medicare and other medical payment levels; our ability to open care centers, acquire additional care centers and integrate and operate these care centers effectively; competition in the healthcare industry; changes in the case mix of patients, the episodic versus non-episodic mix of our payors and payment methodologies; changes in estimates and judgments associated with critical accounting policies; our ability to maintain or establish new patient referral sources; our ability to consistently provide high-quality care; our ability to attract and retain qualified personnel; our ability to keep our patients and employees safe; changes in payments and covered services by federal and state governments; future cost containment initiatives undertaken by third-party payors; our access to financing; our ability to meet debt service requirements and comply with covenants in debt agreements; business disruptions due to natural disasters, climate change or acts of terrorism, widespread protests or civil unrest; our ability to integrate, manage and keep our information systems secure; the impact of inflation; our ability to realize the anticipated benefits of acquisitions, investments and joint ventures; and changes in laws or developments with respect to any litigation relating to the Company, including various other matters, many of which are beyond our control.
More NewsView More
Wall Street’s Sleeping Giant: Is Amazon About to Wake Up? ↗
Today 18:29 EST
Via MarketBeat
Checkmate in the Cloud: ServiceNow's Shopping Spree ↗
Today 18:16 EST
Via MarketBeat
The Contrarian Case for MSTR Amid MSCI Delisting Debacle ↗
Today 17:46 EST
Via MarketBeat
Tickers
MSTR
Worried About Mag 7 Concentration Risk? This ETF Could Help ↗
Today 16:16 EST
Recent QuotesView More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|

